BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25247851)

  • 21. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective pragmatic approach of diagnosis of multidrug-resistant tuberculosis by high-resolution melt curve assay.
    Negi SS; Singh P; Bhargava A; Chandrakar S; Gaikwad U; Das P; Behra A
    Int J Mycobacteriol; 2018; 7(3):228-235. PubMed ID: 30198501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.
    Dantes R; Metcalfe J; Kim E; Kato-Maeda M; Hopewell PC; Kawamura M; Nahid P; Cattamanchi A
    PLoS One; 2012; 7(5):e37956. PubMed ID: 22649569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
    Somoskovi A; Dormandy J; Mitsani D; Rivenburg J; Salfinger M
    J Clin Microbiol; 2006 Dec; 44(12):4459-63. PubMed ID: 17035488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Analysis of
    Purkan P; Ihsanawati I; Natalia D; Syah YM; Retnoningrum DS; Siswanto I
    J Med Life; 2018; 11(2):160-167. PubMed ID: 30140323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of S315T mutation in the katg gene as a strategy for identification of isoniazid-resistant Mycobacterium tuberculosis in a reference laboratory].
    Romay Z; Arráiz N; Fuenmayor A; Ramírez C; Rojas L; París R
    Rev Chilena Infectol; 2012 Dec; 29(6):607-13. PubMed ID: 23412028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T.
    Kapetanaki SM; Chouchane S; Yu S; Magliozzo RS; Schelvis JP
    J Inorg Biochem; 2005 Jun; 99(6):1401-6. PubMed ID: 15917090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic and phenotypic characteristics of tunisian isoniazid-resistant Mycobacterium tuberculosis strains.
    Soudani A; Hadjfredj S; Zribi M; Messaadi F; Messaoud T; Masmoudi A; Zribi M; Fendri C
    J Microbiol; 2011 Jun; 49(3):413-7. PubMed ID: 21717327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Sharma S; Madan M; Agrawal C; Asthana AK
    Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
    Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
    Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
    Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia.
    Varghese B; Hillemann A; Wijayanti DR; Shoukri M; Al-rabiah F; Al-Omari R; Al-Hajoj S
    Infect Genet Evol; 2012 Apr; 12(3):549-56. PubMed ID: 22326932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens.
    Rivière E; Whitfield MG; Nelen J; Heupink TH; Van Rie A
    Clin Microbiol Infect; 2020 Oct; 26(10):1332-1337. PubMed ID: 32653663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
    Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.